...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ZHCLF up 290% to $0.16...question

If Josh4580 CUSIP # on his ZCC  share purchase on the OTC was the same as ZCC in Calgary which it looks like it is then I am assuming there is a way to buy and sell via some brokers .  Wondering if DM will talk about this at the AGM?

Will there be an IPO finally ?  If Repare therapeutics,  from Vancouver can do it , why not Zenith, unless a BP deal is close in hand and thus no need for further funds.....

 

 

Share
New Message
Please login to post a reply